Abstract:<h3> Background</h3><p>Influenza is a highly contagious disease with global annual outbreaks of 3–5 million severe cases and 0.25 to 0.5 million deaths. The risk is greater in pregnant women that results in high morbidity and mortality.</p><h3> Objective</h3><p>The objective of this study was to see the efficacy of influenza vaccine on pregnant women and their newborn upto six months.</p><h3> Method</h3><p>This was a retrospective study (January 2016–March 2018). Records of 346 pregnant women were included in this study (vaccinated: 288; unvaccinated: 58). Women and infants were categorized into Category A, B or C according to the guidelines issued by the Ministry of Health and Family Welfare, India on influenza.</p><h3> Results</h3><p>The groups were comparable with respect to baseline characteristics. Greater number of women received influenza vaccine during the 1<sup>st</sup> trimester (n=117). During the gestation period, majority of the women in the vaccinated group were symptom free compared to the unvaccinated (92% vs 70.7%). Also, none of the vaccinated women were categorized into category C compared to one who was laboratory tested positive for influenza in the unvaccinated group. Similar results were seen postpartum and more number of infants remained symptoms free in the vaccinated group compared with unvaccinated (69.3% vs 25.9%). More number of infants were born pre‐term in the unvaccinated group compared to vaccinated (15.5% vs 8.6%). </p><h3> Conclusions</h3><p>Immunization with influenza vaccine in any trimester during pregnancy was found to protect the mother and infants upto 6 months of age against seasonal influenza without significant maternal adverse effects. In order to improve vaccination rates, there must be a national vaccination policy and incorporation of maternal immunisation in standard antenatal care.</p><p>This article is protected by copyright. All rights reserved.</p><h3> Background</h3><p>Influenza is a highly contagious disease with global annual outbreaks of 3–5 million severe cases and 0.25 to 0.5 million deaths. The risk is greater in pregnant women that results in high morbidity and mortality.</p><h3> Objective</h3><p>The objective of this study was to see the efficacy of influenza vaccine on pregnant women and their newborn upto six months.</p><h3> Method</h3><p>This was a retrospective study (January 2016–March 2018). Records of 346 pregnant women were included in this study (vaccinated: 288; unvaccinated: 58). Women and infants were categorized into Category A, B or C according to the guidelines issued by the Ministry of Health and Family Welfare, India on influenza.</p><h3> Results</h3><p>The groups were comparable with respect to baseline characteristics. Greater number of women received influenza vaccine during the 1<sup>st</sup> trimester (n=117). During the gestation period, majority of the women in the vaccinated group were symptom free compared to the unvaccinated (92% vs 70.7%). Also, none of the vaccinated women were categorized into category C compared to one who was laboratory tested positive for influenza in the unvaccinated group. Similar results were seen postpartum and more number of infants remained symptoms free in the vaccinated group compared with unvaccinated (69.3% vs 25.9%). More number of infants were born pre‐term in the unvaccinated group compared to vaccinated (15.5% vs 8.6%). </p><h3> Conclusions</h3><p>Immunization with influenza vaccine in any trimester during pregnancy was found to protect the mother and infants upto 6 months of age against seasonal influenza without significant maternal adverse effects. In order to improve vaccination rates, there must be a national vaccination policy and incorporation of maternal immunisation in standard antenatal care.</p><p>This article is protected by copyright. All rights reserved.</p>

Influenza in Pregnancy: Maternal, Obstetric, and Fetal Implications, Diagnosis, and Management

Pregnancy and severe influenza infection in the 2013-2014 influenza season

Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants

Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications

One “misunderstood” health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis

Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis

Maternal vaccination for the prevention of influenza: current status and hopes for the future

Pregnancy Downregulates Plasmablast Metabolic Gene Expression Following Influenza Without Altering Long-Term Antibody Function

Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy

25 Cases Clinical Analysis of Pregnancy Complicated with Confirmed Influenza A(H_1N_1) Infection

H1N1 novel influenza A in pregnant and immunocompromised patients

The Effect of Influenza Virus Infection on Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Cohort Studies

A Systematic Review and Meta-Analysis of Influenza A Virus Infection During Pregnancy Associated with an Increased Risk for Stillbirth and Low Birth Weight

Influenza vaccine: A viable option to protect pregnant women and infants from seasonal flu: A retrospective hospital‐based study in India

Influenza Infection During Pregnancy and Risk of Seizures in Offspring.

Pandemic Influenza A(H1N1) 2009 Virus in Pregnancy

Risk of severe influenza infection in women with a history of pregnancy complications: A longitudinal cohort study

Immune Influence of Pregnancy on Human H7N9 Infection: a Case Report.

Risk of preterm birth in maternal influenza or SARS-CoV-2 infection: a systematic review and meta-analysis

Association Between Influenza Vaccination and SARS‐CoV‐2 Infection

Influenza vaccination in pregnant women in Iceland 2010–2020 and the burden of influenza in pregnant women and their infants